The largest database of trusted experimental protocols

Anti par antibody

Manufactured by Bio-Techne
Sourced in United States

The Anti-PAR antibody is a laboratory reagent used for the detection and quantification of poly(ADP-ribose) (PAR) in biological samples. PAR is a post-translational modification involved in various cellular processes, and the Anti-PAR antibody can be used to study its roles and dynamics.

Automatically generated - may contain errors

8 protocols using anti par antibody

1

TARG1-mediated PAR hydrolysis assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
TARG1-type macrodomain PAR hydrolysis was determined by western blot33 (link). The substrate used was automodified hPARP obtained as described above using NAD+ and activated DNA as substrates and Rucaparib to stop the reaction. Then, this PARylated substrate was incubated for 1 hour at 30 °C in the presence of FmTARG1 (20 μM) or hTARG1 (10 μM), before running the samples on 7–10% SDS-PAGE gels and transfering to a nitrocellulose membrane. The presence of PAR was detected by coupling with rabbit polyclonal anti-PAR antibodies (1:1000, Trevigen) and goat-anti-rabbit-HRP conjugated secondary antibody (Bio-Rad), and finally revealed with Opti-4CN substrate (Bio-Rad) for 5 minutes. Analysis of the reaction products of hTARG1 and FmTARG1 on poly (ADP-ribosyl)ated PARP1 was carried out by mass spectrometry as described above for the de-MARylation assay.
+ Open protocol
+ Expand
2

Quantifying PARP Automodification and PARG-Mediated PAR Hydrolysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
PARP automodification was also assayed by western blot in a reaction containing different concentrations of enzyme (250 nM HaPARP, 200 nM CdPARP, or 85 nM hPARPl) in assay buffer, with or without NAD+ (1 mM), activated DNA or rucaparib (1 µM), respectively. The reactions were allowed to proceed for 1 h at 25 °C. PAR-mediated PARG hydrolysis was analysed using the above-mentioned PARP automodification reaction after stopping it with rucaparib, followed by the addition of PARG enzymes (500 nM) and incubation for 1 hour at 30 °C. The above reactions were then run on 7–10% SDS-PAGE gels and transferred to a nitrocellulose membrane. The presence of poly ADP-ribose (PAR) was detected by the use of rabbit polyclonal anti-PAR antibodies (1:1000; Trevigen), and goat anti-Rabbit IgG antibody conjugated to horseradish peroxidase (1:5000; Bio-Rad), and Opti-4CN as optimized colorimetric substrate (Bio-Rad).
+ Open protocol
+ Expand
3

Characterizing EXO1 Interactions and Variants

Check if the same lab product or an alternative is used in the 5 most similar protocols
GFP-EXOI plasmids were a gift from Zhongsheng You. N-terminus (a.a. 1–352), middle region (a.a. 353–549) and C-terminus (a.a .550–846) of EXO1, SMG5-PIN (a.a. 831–1016), GEN1-PIN (a.a. 1–210) were cloned into pEGFP-C1 or pGEX-4T vector. The EXO1 natural variants and siRNA resistant forms were generated using the QuikChange site-directed mutagenesis kit (Stratagene).
The siRNA sequences targeting PARP1, PARP2, MSH3 and EXO1 are 5′-CAAAGUAUCCCAAGAAGUUdTdT-3′, 5′-GGAGAAGGAUGGUGAGAAAdTdT-3′, 5′-GAAGAACAAUAUCCUACUAdTdT-3′ and 5′-CAAGCCUAUUCUCGUAUUUdTdT-3′ respectively. siRNAs were transfected into cells using oligofectamine (Invitrogen) according to manufacturer's instructions.
Anti β-actin, anti-biotin, anti-EXO1 and anti-GFP antibodies were purchased from Sigma. Anti-PARP1 and anti-PARP2 antibodies were purchased from Millipore. Anti-PAR antibody was purchased from Trevigen. Anti- RPA32 and phospho-H2AX (γ-H2AX) were purchased from Cell Signaling.
+ Open protocol
+ Expand
4

Targeted Cancer Therapy Compound Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
YHP-836 was synthesized in-house. PARP1/2 inhibitor olaparib was purchased from TargetMol, United States. Temozolomide (TMZ), topotecan, cisplatin, and adriamycin were purchased from J&K Scientific (Beijing, China). Anti-γH2AX and anti-RAD51 were obtained from Cell Signaling Technology (Danvers, MA, United States). An anti-β-actin antibody was purchased from Santa Cruz Biotechnology (Dallas, TX, United States). Anti-PARP1 and anti-PARP2 antibodies were from Abcam (Cambridge, United Kingdom). Anti-PAR antibody and HT PARP pharmacodynamic assay kit were purchased from Trevigen (Gaithersburg, MD, United States). The subcellular protein fractionation kit was purchased from Thermo Scientific (Rockford, IL, United States).
+ Open protocol
+ Expand
5

Immunoprecipitation and Western Blotting

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were lysed in lysis buffer (50 mM Tris-HCl [pH 8.0], 5 mM EDTA, 150 mM NaCl, 0.5% NP-40, and 1 mM phenylmethylsulfonyl fluoride). Cell lysate (200-1000 µg of protein) was immunoprecipitated with anti-PARP antibody (Cell Signaling, Boston, MA), anti-MGMT antibody (Sigma), or anti-PAR antibody (Trevigen) for 18 hours at 4°C. Normal preimmune mouse and rabbit IgG (Cell Signaling Technology, Boston, MA) was also used as negative controls. The immunoprecipitates were eluted by the 2× SDS sample buffer and then detected by Western blot analysis.
+ Open protocol
+ Expand
6

Histone PARylation Detection in U2OS Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
U2OS cells were lysed with NETN-100 buffer (50 mM Tris–HCl pH 8.0, 100 mM NaCl, 2 mM EDTA, 0.5% Nonidet P-40) on ice for 30 min. Soluble fractions were subjected to immunoprecipitation and dot blotting and probed with anti-PAR antibody (Trevigen). For detecting histone PARylation, cells were lysed with 0.5% SDS and the lysates were diluted to 0.1% SDS for immunoprecipitation with anti-histone antibodies. The samples were subjected to dot blotting assay using anti-PAR antibody. To validate the recognition of SSRP1 to PARylated histone, cells were lysed with NETN-100 buffer and the lysates were immunoprecipitated with anti-SSRP1 or anti-FLAG antibodies. The immunoprecipitated proteins were eluted from the beads by 0.5% SDS and diluted to 0.1% SDS for the second round of immunoprecipitation with the anti-PAR antibody and blotting with anti-H2B antibody.
+ Open protocol
+ Expand
7

Protein Expression Analysis by Western Blot

Check if the same lab product or an alternative is used in the 5 most similar protocols
Protein levels were assessed by western blot. Antibodies against HDAC, PARP, cleaved-PARP, H3, Acetyl-H3, and RAD51 were purchased from Cell Signaling Technology (CST). Anti-UHRF1, Ku-70, ERCC1, MSH2, MSH6, GAPDH and anti-α-tublin antibodies were purchased from Santa Cruz Biotechnology (Dallas, TX, USA). Anti-BRCA1 and phosphorylated-BRCA1(ser988) was purchased from ABclonal Technology (Upper Heyford, UK). Anti-PAR antibody was purchased from Trevigen (4335-MC-100, MD, USA).
+ Open protocol
+ Expand
8

PARP-2 Automodification and DNA Binding Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
PARP-2 WT (60 nM) was incubated with 60 nM DNA (dnick or dnick 5′P) for 30 min at
RT in the presence of 25 μM NAD+ in the same buffer conditions as the
radioactive and colorimetric assays. In Supplementary Figure S6, PARP-2 WT and L269A (60
nM) were incubated with 25 μM NAD+ in the absence of DNA. Reactions were
stopped by the addition of SDS-PAGE loading buffer, incubated for 5 min at 95°C,
resolved on 10% SDS-PAGE (50 ng of protein) and blotted onto Hybond-ECL
Nitrocellulose membrane (Bio-Rad). Membranes were blocked for 1 h (RT) in the following
buffer: tris-buffered saline with tween (TBST; 20 mM Tris pH 7.5, 150 mM NaCl, 0.1%
Tween 20) supplemented with 5% blocking-grade blocker (Bio-Rad). Blots were
incubated 1 h (RT) with a 1:2000 anti-PAR antibody (Trevigen) in blocking buffer and
washed with TBST and TBS then incubated with 1:7000 HRP conjugated donkey anti-rabbit
antibody (Santa Cruz Biotechnology) in 1% blocking-grade buffer in TBST. Blots were
washed and developed with SuperSignal West Pico Chemiluminescent Substrate (Thermo
Scientific).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!